Youshu (sumatriptan succinate) / Simcere - LARVOL DELTA

Two new species of freshwater goby (Teleostei, Gobiidae) from the Upper Youshui River, Chongqing, China. (PubMed, Zookeys) - "The head and body of this species are light gray with irregular orange markings on the cheeks and opercle. Through morphological and molecular analyses, it has been confirmed that R.lithopolychroma and R.sudoccidentalis represent novel species within the Rhinogobius genus."

Journal

Application of Data Analysis and Data Visualization in Medical Equipment: Take Infusion Pump as Example (PubMed, Zhongguo Yi Liao Qi Xie Za Zhi) - "The maintenance system of infusion pump system is simple and clear, with good visualization effect. It can quickly analyze maintenance failures, reduce maintenance times and maintenance costs, ensure the safety of the equipment. Moreover, the system can be easily transferred to other medical equipment, and can carry on the whole life cycle data research."

Journal

"#willyoushutupman the theme of the night" (@BrandonHillPhD)

"#willyoushutupman the theme of the night." (@BrandonHillPhD)

Stomatal and Photosynthetic Traits Are Associated with Investigating Sodium Chloride Tolerance of Brassica napus L. Cultivars. (PubMed, Plants (Basel)) - "Among the photosynthetic gas exchange and anatomical traits, the stomatal aperture was the most highly correlated with salinity tolerance in rapeseed cultivars and thus, is important for future studies that aim to improve salinity tolerance in rapeseed. Thus, we identified and characterized two salt-tolerant cultivars that will be useful for breeding programs that aim to develop salt-tolerant rapeseed."

Journal

Navigating effective approaches to migraine treatment for the underinsured (Neurology Advisor) - "'Migraine is managed most commonly by primary care physicians and general neurologists, as headache specialists specifically are quite scarce,' Matthew Robbins...Dr Robbins elaborated on the challenges to getting insurers to cover the best available treatments, even for those who have adequate coverage. 'Newer treatments such as calcitonin gene-related peptide antibodies and neuromodulation devices are expensive and not yet widely covered by all insurances, particularly with government-sponsored programs,' he said....'Fortunately, there remain many medication and nonmedication therapies for migraine that are much less costly than some of the newer treatments,' he said."

Media quote